Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : > Health Centers > Drug News -
FDA approval for chewable ADHD tablets FDA approval for chewable ADHD tablets

FDA approval for chewable ADHD tablets

Drug NewsSep 11, 2004

Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.

Compliance with any medical therapy is important. With children, the issue is pronounced, as swallowing pills can be a significant problem. Says Dr. Lyndon Waugh, M.D., Clinical Assistant Professor of Child and Adolescent Psychiatry at Emory University, “The release of this effective, well established medication for ADHD in liquid and chewable tablet form will allow physicians another alternative to carefully fine-tune a dosing strategy for each individual patient.

And, it will help diminish family conflict and the child’s anxiety when they have difficulty swallowing capsules or tablets.”

Currently 26% of the total population has difficulty in swallowing tablets and capsules. This percentage is considered to be higher in the pediatric patient population.

ADHD is a disorder of the brain in which the individual repeatedly exhibits inappropriate impulsivity and/or inattention. According to the Attention Deficit Disorder Association, an estimated 3 to 7 percent of school- age children, and an estimated 4 percent of adults suffer from ADHD. The Attention Deficit Disorder Association was instrumental in convincing the U.S. Senate to sign a resolution designating September 7, 2004, “National Attention Deficit Disorder Awareness Day” in hopes of better educating the public about ADHD.

“As with any medication, compliance is critical,” adds Mark Pugh, President and CEO of Alliant Pharmaceuticals. “Methylin Chewable Tablet and Methylin Oral Solution were designed specifically to help improve efficacy in treatment.” Mr. Pugh adds that Alliant plans to release additional information on these products at the upcoming American Academy of Adolescent and Child Psychiatry meeting October 20 - 23rd in Washington D.C.

Methylin Chewable Tablets are available in a 2.5mg, 5mg and 10mg dose. The Methylin Oral Solution is available in a 5mg/5mL and 10mg/5mL dose.

Provided by ArmMed Media
Revision date: July 9, 2011
Last revised: by Tatiana Kuznetsova, D.M.D.

FDA approval for chewable ADHD tablets Bookmark this! FDA approval for chewable ADHD tablets


We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids. Commenting is not available in this weblog entry.

   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above

Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on

Health Centers


Health news

Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools

   Health newsletter


   Medical Links

   RSS/XML News Feed


Add to Yahoo RSS News Feed

Google Reader


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.